New framework agreement focuses on a loan repayment plan, allowing the pharmaceutical firm to refocus on its core CNS pipeline.
The unsolicited offer represents a 53% premium, as Mobix escalates its takeover attempt for the semiconductor firm.
Deal with Deriva Energy expected to be immediately accretive, boosting renewable energy assets and targeting a cash available for distribution (CAFD) yield over 12%.
The merger signals accelerating consolidation within the U.S. regional banking sector, creating the nation's 9th largest bank.
The deal will see the Singapore-based social technology company list on the Nasdaq, valuing the combined entity at approximately $300 million.
The marketing application for AVT23, a biosimilar to the multi-billion dollar asthma drug Xolair, marks a key regulatory step for Alvotech in the European market.
Investors are closely watching the beverage giant's Q3 results on Monday for insights into the health of the alcoholic beverage market.
First patients implanted with the novel neurostimulator marks a key step in challenging market leader Inspire Medical after recent FDA approval.